Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Luchini C, Fleischmann A, Boormans JL et al (2017) Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis. Sci Rep 7:2347. https://doi.org/10.1038/s41598-017-02577-4

Article  CAS  Google Scholar 

Boormans JL, Mark FW, Chris HB et al (2008) Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer. BJU Int 41:1589–1593. https://doi.org/10.1111/j.1464-410X.2008.07904.x

Article  Google Scholar 

Adams J, Cheng L (2011) Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome. Expert Rev Anticancer Ther 11:1457–1469. https://doi.org/10.1586/era.11.104

Article  PubMed  Google Scholar 

Schiavina R, BorghesiBrunocilla ME et al (2013) Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score. BJU Int 111:1237–1244. https://doi.org/10.1111/j.1464-410X.2012.11602.x

Article  PubMed  Google Scholar 

Lydiatt WM, Patel SG, O’Sullivan B et al (2017) Head and neck cancers major changes in the American joint committee. CA Cancer J Clin 67:122–137. https://doi.org/10.3322/caac.21389

Article  PubMed  Google Scholar 

Karakurt EM, Kadıyoran C (2022) prognostic significance of radiologic extranodal extension in nasopharyngeal cancer. Otolaryngol Head Neck Surg 166:321–326. https://doi.org/10.1177/01945998211008887

Article  Google Scholar 

Cornford P, van de BRCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79:263–282. https://doi.org/10.1016/j.eururo.2020.09.046

Article  CAS  PubMed  Google Scholar 

Varma M, Cochlin D, Delahunt B et al (2019) TNM clinical staging of prostate cancer: issues and solutions. BJU Int 123:382–384. https://doi.org/10.1111/bju.14589

Article  PubMed  Google Scholar 

Zhang J, Shao S, Wu P et al (2019) Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging 46:908–920. https://doi.org/10.1007/s00259-018-4255-1

Article  PubMed  Google Scholar 

Padhani AR, Weinreb J, Rosenkrantz AB et al (2019) Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions. Euro Urol 75:385–396. https://doi.org/10.1016/j.eururo.2018.05.035

Article  Google Scholar 

Gensheimer MF, Le Q (2019) Radiographic extranodal extension in human papillomavirus-associated oropharyngeal carcinoma: can it help tailor treatment. Int J Radiat Oncol Biol Phys 104:1028–1029. https://doi.org/10.1016/j.ijrobp.2019.05.022

Article  PubMed  Google Scholar 

Lee B, Choi JY, Kim SO et al (2019) Prognostic value of radiologic extranodal extension in human papillomavirus-related oropharyngeal squamous cell carcinoma. Korean J Radiol 20:1266–1274. https://doi.org/10.3348/kjr.2018.0742

Article  PubMed  PubMed Central  Google Scholar 

Faraji F, Aygun N, Coquia SF et al (2020) Computed tomography performance in predicting extranodal extension in HPV-positive oropharynx cancer. Laryngoscope 130:1479–1486. https://doi.org/10.1002/lary.28237

Article  CAS  PubMed  Google Scholar 

Noor A, Mintz J, Patel S et al (2019) Predictive value of computed tomography in identifying extracapsular spread of cervical lymph node metastases in p16 positive oropharyngeal squamous cell carcinoma. J Med Imaging Radiat Oncol 63:500–509. https://doi.org/10.1111/1754-9485.12888

Article  PubMed  Google Scholar 

Horváth A, Prekopp P, Polony G et al (2021) Accuracy of the preoperative diagnostic workup in patients with head and neck cancers undergoing neck dissection in terms of nodal metastases. Eur Arch Otorhinolaryngol 278:2041–2046. https://doi.org/10.1007/s00405-020-06324-w

Article  PubMed  Google Scholar 

Tian S, Ferris MJ, Switchenko JM et al (2019) Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma. Head Neck 41:3056–3063. https://doi.org/10.1002/hed.25791

Article  PubMed  PubMed Central  Google Scholar 

Paner GP, Stadler WM, Hansel DE et al (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73:560–569. https://doi.org/10.1016/j.eururo.2017.12.018

Article  PubMed  Google Scholar 

Offermann A, Hupe MC, Sailer V et al (2020) The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature. World J Urol 38:657–662. https://doi.org/10.1007/s00345-019-02744-4

Article  CAS  PubMed  Google Scholar 

Tsai T, Chou Y, Lu Y et al (2021) The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: systematic review and meta-analysis. Oral Oncol 122:105518. https://doi.org/10.1016/j.oraloncology.2021.105518

Article  PubMed  Google Scholar 

Mao Y, Wang S, Lydiatt W et al (2021) Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems. Radiother Oncol 157:114–121. https://doi.org/10.1016/j.radonc.2021.01.015

Article  PubMed  Google Scholar 

Furesi G, Rauner M, Hofbauer LC et al (2021) Emerging players in prostate cancer-bone niche communication. Trends Cancer 7:112–121. https://doi.org/10.1016/j.trecan.2020.09.006

Article  CAS  PubMed  Google Scholar 

Chen R, Yang Q, Chen W et al (2021) Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer. World J Urol 39:2937–2943. https://doi.org/10.1007/s00345-020-03571-8

Article  PubMed  Google Scholar 

Hofman MS, Lawrentschuk N, Francis RJ et al (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208–1216. https://doi.org/10.1007/s00345-020-03571-8

Article  CAS  PubMed  Google Scholar 

Tuncel M, Tuncalı MÇ, Telli T et al (2020) Clinical impact of PET imaging in patients with metastatic prostate cancer. Clin Nucl Med 45:757–764. https://doi.org/10.1097/RLU.0000000000003126

Article  PubMed  Google Scholar 

Berish RB, Ali AN, Telmer PG et al (2018) Translational models of prostate cancer bone metastasis. Nat Rev Urol 15:403–421. https://doi.org/10.1038/s41585-018-0020-2

Article  CAS  PubMed  Google Scholar 

Padhani AR, Lecouvet FE, Tunariu N et al (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71:81–92. https://doi.org/10.1016/j.eururo.2016.05.033

Article  PubMed  PubMed Central  Google Scholar 

Rowe SP, Pienta KJ, Pomper MG et al (2018) PSMA-RADS Version 1.0: a step towards standardizing the interpretation and reporting of PSMA–targeted PET imaging studies. Eur Urol 73:485–487. https://doi.org/10.1016/j.eururo.2017.10.027

Article  PubMed  Google Scholar 

Pomykala KL, Czernin J, Grogan TR et al (2020) Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: potential impact on bone scan guidelines. J Nucl Med 61:405–411. https://doi.org/10.2967/jnumed.119.230318

Article  CAS  PubMed  PubMed Central  Google Scholar